Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard F Clark

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 31, 2017
Fragment-based discovery of a potent NAMPT inhibitorAlla Korepanova, Kenton L Longenecker, Steve D Pratt, et al.
Journal of the American College of Emergency Physicians Open|December 7, 2022
Accidental organophosphate poisoning: A case series of 2 pediatric coumaphos exposuresJustin A Seltzer, Sarah Friedland, Nathan A Friedman, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2006
Structure-activity relationships for a novel series of thiazolyl phenyl ether derivatives exhibiting potent and selective acetyl-CoA carboxylase 2 inhibitory activityRichard F Clark, Tianyuan Zhang, Zhili Xin, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Structure-activity relationships of novel potent MurF inhibitorsYu Gui Gu, Alan S Florjancic, Richard F Clark, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2021
Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferasesZhiqin Ji, Richard F Clark, Vikram Bhat, et al.
Journal of Medicinal Chemistry|June 23, 2006
Synthesis and structure-activity relationships of N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1- methylprop-2-ynyl}carboxy derivatives as selective acetyl-CoA carboxylase 2 inhibitorsYu Gui Gu, Moshe Weitzberg, Richard F Clark, et al.
Chemical Biology & Drug Design|February 24, 2006
Structure-based optimization of MurF inhibitorsGeoffrey F Stamper, Kenton L Longenecker, Elizabeth H Fry, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Novel inhibitors of bacterial protein synthesis: structure-activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variantsRichard F Clark, Sanyi Wang, Zhenkun Ma, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2017
SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED bindingMichael L Curtin, Marina A Pliushchev, Huan-Qiu Li, et al.
Clinical Toxicology (Philadelphia, Pa.)|November 1, 2014
Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trialSean P Bush, Anne-Michelle Ruha, Steven A Seifert, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Bioorganic & Medicinal Chemistry Letters|December 31, 2017
Fragment-based discovery of a potent NAMPT inhibitorAlla Korepanova, Kenton L Longenecker, Steve D Pratt, et al.
Journal of the American College of Emergency Physicians Open|December 7, 2022
Accidental organophosphate poisoning: A case series of 2 pediatric coumaphos exposuresJustin A Seltzer, Sarah Friedland, Nathan A Friedman, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2006
Structure-activity relationships for a novel series of thiazolyl phenyl ether derivatives exhibiting potent and selective acetyl-CoA carboxylase 2 inhibitory activityRichard F Clark, Tianyuan Zhang, Zhili Xin, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Structure-activity relationships of novel potent MurF inhibitorsYu Gui Gu, Alan S Florjancic, Richard F Clark, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2021
Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferasesZhiqin Ji, Richard F Clark, Vikram Bhat, et al.
Journal of Medicinal Chemistry|June 23, 2006
Synthesis and structure-activity relationships of N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1- methylprop-2-ynyl}carboxy derivatives as selective acetyl-CoA carboxylase 2 inhibitorsYu Gui Gu, Moshe Weitzberg, Richard F Clark, et al.
Chemical Biology & Drug Design|February 24, 2006
Structure-based optimization of MurF inhibitorsGeoffrey F Stamper, Kenton L Longenecker, Elizabeth H Fry, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Novel inhibitors of bacterial protein synthesis: structure-activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variantsRichard F Clark, Sanyi Wang, Zhenkun Ma, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2017
SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED bindingMichael L Curtin, Marina A Pliushchev, Huan-Qiu Li, et al.
Clinical Toxicology (Philadelphia, Pa.)|November 1, 2014
Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trialSean P Bush, Anne-Michelle Ruha, Steven A Seifert, et al.
Pageof 17